Clinical studies confirmed that the peptide produces no changes in serum IGF-1 levels, eliminating the appetite-stimulating effects associated with growth hormone therapy
10.1038/s41591-023-02344-1 26 GarberA.HenryR.RatnerR.Garcia-HernandezP
Once activated, satellite cells can fuse with existing muscle fibers to repair them or, in some cases, form entirely new muscle fibers
Data Human Data In an open-label clinical trial, 185 pregnant females with type 1 diabetes were treated with either TRESIBA (once daily) or insulin detemir (once or twice daily)
Obesity is now recognized as a chronic, relapsing disease associated with increased risk of more than 200 conditions, including [3]: Type 2 diabetes Cardiovascular disease Obstructive sleep apnea Certain cancers Increased overall mortality Beyond individual patient risk, the system-level burden is substantial